{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T18:36:25Z","timestamp":1694630185575},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2002,12]]},"DOI":"10.1007\/s11908-002-0043-x","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T03:21:55Z","timestamp":1180063315000},"page":"543-549","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Management of occupational and nonoccupational postexposure HIV prophylaxis"],"prefix":"10.1007","volume":"4","author":[{"given":"Mitchell H.","family":"Katz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie Louise","family":"Gerberding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"43_CR1","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1056\/NEJM199711203372101","volume":"337","author":"DM Cardo","year":"1997","unstructured":"Cardo DM, Culver DH, Ciesielski CA, et al.: A case-control study of HIV seroconversion in health care workers after percutaneous exposure. N Engl J Med 1997, 337:1485\u20131490.","journal-title":"N Engl J Med"},{"key":"43_CR2","first-page":"RR","volume":"50","author":"Centers for Disease Control and Prevention","year":"2001","unstructured":"Centers for Disease Control and Prevention: Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR 2001, 50(RR-11). Centers for Disease Control guidelines for management of occupational exposures.","journal-title":"MMWR"},{"key":"43_CR3","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1001\/jama.281.10.931","volume":"281","author":"DK Henderson","year":"1999","unstructured":"Henderson DK: Postexposure chemoprophylaxis for occupational exposures to the human immunodeficiency virus. JAMA 1999, 281:931\u2013936.","journal-title":"JAMA"},{"key":"43_CR4","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1056\/NEJM199704103361512","volume":"336","author":"MH Katz","year":"1997","unstructured":"Katz MH, Gerberding JL: Postexposure treatment of people exposed to the human immunodeficiency virus through sexual contact or injection-drug use. N Engl J Med 1997, 336:1097\u20131100.","journal-title":"N Engl J Med"},{"key":"43_CR5","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1001\/jama.280.20.1769","volume":"280","author":"P Lurie","year":"1998","unstructured":"Lurie P, Miller S, Hecht F, et al.: Postexposure prophylaxis after nonoccupational HIV exposure. JAMA 1998, 280:1769\u20131773.","journal-title":"JAMA"},{"key":"43_CR6","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/00002030-200202150-00011","volume":"16","author":"A Laporte","year":"2002","unstructured":"Laporte A, Jourdan N, Bouvet E, et al.: Post-exposure prophylaxis after non-occupational HIV exposure: impact of recommendations on physicians\u2019 experiences and attitudes. AIDS 2002, 16:397\u2013405.","journal-title":"AIDS"},{"key":"43_CR7","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1136\/sti.74.4.304","volume":"74","author":"GR Kinghorn","year":"1998","unstructured":"Kinghorn GR, Evans B, Nunn A, et al.: Post-exposure prophylaxis (PEP) after non-occupational risk of HIV infection. Sex Transm Infect 1998, 74:304.","journal-title":"Sex Transm Infect"},{"key":"43_CR8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.7326\/0003-4819-125-6-199609150-00011","volume":"125","author":"JL Gerberding","year":"1996","unstructured":"Gerberding JL: Prophylaxis for occupational exposure to HIV. Ann Intern Med 1996, 125:497\u2013501.","journal-title":"Ann Intern Med"},{"key":"43_CR9","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/0895-4356(89)90098-X","volume":"42","author":"V DeGruttola","year":"1989","unstructured":"DeGruttola V, Seage GR III, Mayer KH, Horsburgh CRJr: Infectiousness of HIV between male homosexual partners. J Clin Epidemiol 1989, 42:849\u2013856.","journal-title":"J Clin Epidemiol"},{"key":"43_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/sim.4780080110","volume":"8","author":"JA Wiley","year":"1989","unstructured":"Wiley JA, Herschkorn SJ, Padian NS: Heterogeneity in the probability of HIV transmission per sexual contact: the case of male-to-female transmission in penile-vaginal intercourse. Stat Med 1989, 8:93\u2013102.","journal-title":"Stat Med"},{"key":"43_CR11","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/00042560-199604010-00010","volume":"11","author":"AM Downs","year":"1996","unstructured":"Downs AM, De Vincenzi I: Probability of heterosexual transmission of HIV: relationship to the number of unprotected sexual contacts. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 11:388\u2013395.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"43_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1001\/jama.259.1.55","volume":"259","author":"TA Peterman","year":"1988","unstructured":"Peterman TA, Stoneburner RL, Allen JR, et al.: Risk of human immunodeficiency virus transmission from heterosexual adults with transfusion-associated infections. JAMA 1988, 259:55\u201358. [Erratum, JAMA 1989, 262:502.]","journal-title":"JAMA"},{"key":"43_CR13","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/oxfordjournals.aje.a010003","volume":"150","author":"E Vittinghoff","year":"1999","unstructured":"Vittinghoff E, Douglas J, Judson F, et al.: Per-contact risk of human immunodeficiency virus transmission between male sexual partners. Am J Epidemiol 1999, 150:306\u2013311.","journal-title":"Am J Epidemiol"},{"key":"43_CR14","first-page":"1116","volume":"5","author":"EH Kaplan","year":"1992","unstructured":"Kaplan EH, Heimer R: A model-based estimate of HIV infectivity via needle sharing. J Acquir Immune Defic Syndr 1992, 5:1116\u20131118.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"43_CR15","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1056\/NEJM199704103361507","volume":"336","author":"R Royce","year":"1997","unstructured":"Royce R, Sena A, Cates WJ, Cohen M: Sexual transmission of HIV. N Engl J Med 1997, 336:1072\u20131078.","journal-title":"N Engl J Med"},{"key":"43_CR16","doi-asserted-by":"crossref","first-page":"642","DOI":"10.2105\/AJPH.86.5.642","volume":"86","author":"SD Holmberg","year":"1996","unstructured":"Holmberg SD: The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am J Public Health 1996, 86:642\u2013654.","journal-title":"Am J Public Health"},{"key":"43_CR17","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S0002-9343(99)00018-2","volume":"106","author":"JD Bamberger","year":"1999","unstructured":"Bamberger JD, Waldo CR, Gerberding JL, Katz MH: Postexposure prophylaxis for human immunodeficiency virus (HIV) infection following sexual assault. Am J Med 1999, 106:323\u2013326. Management of postexpoxure prophylaxis following sexual assault.","journal-title":"Am J Med"},{"key":"43_CR18","first-page":"641","volume":"162","author":"ER Wiebe","year":"2000","unstructured":"Wiebe ER, Comay SE, McGregor M, Ducceschi S: Offering HIV prophylaxis to people who have been sexually assaulted: 16 months\u2019 experience in a sexual assault service. Can Med Assoc J 2000, 162:641\u2013645.","journal-title":"Can Med Assoc J"},{"key":"43_CR19","doi-asserted-by":"crossref","first-page":"306","DOI":"10.7326\/0003-4819-128-4-199802150-00012","volume":"128","author":"MH Katz","year":"1998","unstructured":"Katz MH, Gerberding JL: Managing recent sexual exposures to HIV. Ann Intern Med 1998, 128:306\u2013312. Comprehensive review of management of sexual exposure to HIV.","journal-title":"Ann Intern Med"},{"key":"43_CR20","first-page":"3190","volume":"47","author":"L Tavares","year":"1987","unstructured":"Tavares L, Roneker C, Johnston K, et al.: 3\u2032-Azido-3\u2032-deoxythymidine in feline leukemia virus-infected cats: a model for therapy and prophylaxis of AIDS. Cancer Res 1987, 47:3190\u20133194.","journal-title":"Cancer Res"},{"key":"43_CR21","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1128\/AAC.36.12.2715","volume":"36","author":"LE Mathes","year":"1992","unstructured":"Mathes LE, Polas PJ, Hayes KA, et al.: Pre- and postexposure chemoprophylaxis: evidence that 3\u2032-azido-3\u2032-dideoxythymidine inhibits feline leukemia virus disease by a drug-induced vaccine response. Antimicrob Agents Chemother 1992, 36:2715\u20132721.","journal-title":"Antimicrob Agents Chemother"},{"key":"43_CR22","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/323467a0","volume":"323","author":"RM Ruprecht","year":"1986","unstructured":"Ruprecht RM, O\u2019Brien LG, Rossoni LD, Nusinoff-Lehrman S: Suppression of mouse viraemia and retroviral disease by 3\u2032-azido-3\u2032-deoxythymidine. Nature 1986, 323:467\u2013469.","journal-title":"Nature"},{"key":"43_CR23","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1056\/NEJM199411033311801","volume":"331","author":"EM Connor","year":"1994","unstructured":"Connor EM, Sperling RS, Gelber R, et al.: Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994, 331:1173\u20131180.","journal-title":"N Engl J Med"},{"key":"43_CR24","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1056\/NEJM199811123392001","volume":"339","author":"NA Wade","year":"1998","unstructured":"Wade NA, Birkhead GS, Warren BL, et al.: Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus. N Engl J Med 1998, 339:1409\u20131414.","journal-title":"N Engl J Med"},{"key":"43_CR25","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S0002-9343(97)00062-4","volume":"102","author":"EM Jochimsen","year":"1997","unstructured":"Jochimsen EM: Failures of zidovudine postexposure prophylaxis. Am J Med 1997, 102:52\u201355.","journal-title":"Am J Med"},{"key":"43_CR26","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1086\/318829","volume":"183","author":"JO Kahn","year":"2001","unstructured":"Kahn JO, Martin JN, Roland ME, et al.: Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: The San Francisco PEP Study. J Infect Dis 2001, 183:707\u2013714. Feasibility study of providing nonoccupational postexposure prophylaxis; it demonstrated that it was feasible, adherence to treatment was high, and there were no long-term side effects or seroconversions among the 401 participants.","journal-title":"J Infect Dis"},{"key":"43_CR27","first-page":"1153","volume":"49","author":"Centers for Disease Control and Prevention","year":"2001","unstructured":"Centers for Disease Control and Prevention: Serious adverse events attributed to nevirapine regimens for postexposure prophylaxis after HIV exposures\u2014worldwide, 1997\u20132000. MMWR 2001, 49:1153\u20131156.","journal-title":"MMWR"},{"key":"43_CR28","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/S0140-6736(99)05005-9","volume":"355","author":"JM Parkin","year":"2000","unstructured":"Parkin JM, Murphy M, Anderson J, et al.: Tolerability and sideeffects of post-exposure prophylaxis for HIV infection. Lancet 2000, 355:722\u2013723.","journal-title":"Lancet"},{"key":"43_CR29","doi-asserted-by":"publisher","first-page":"F17","DOI":"10.1097\/00002030-200001280-00003","volume":"14","author":"H Salomon","year":"2000","unstructured":"Salomon H, Wainberg MA, Brenner B, et al.: Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use. AIDS 2000, 14:F17-F23.","journal-title":"AIDS"},{"key":"43_CR30","doi-asserted-by":"crossref","first-page":"502","DOI":"10.7326\/0003-4819-131-7-199910050-00004","volume":"131","author":"SK Brodine","year":"1999","unstructured":"Brodine SK, Shaffer RA, Starkey MJ, et al.: Drug resistance patterns, genetic subtypes, clinical features, and risk factors in military personnel with HIV-1 seroconversion. Ann Intern Med 1999, 131:502\u2013506.","journal-title":"Ann Intern Med"},{"key":"43_CR31","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1001\/jama.287.18.2406","volume":"287","author":"MS Sulkowski","year":"2002","unstructured":"Sulkowski MS, Ray SC, Thomas DL: Needlestick transmission of hepatitis C. JAMA 2002, 287:2406\u20132413.","journal-title":"JAMA"},{"key":"43_CR32","unstructured":"Wang SA, Panlilio AL, the HIV PEP Registry Group: Experience of health-care workers (HCWs) taking postexposure prophylaxis (PEP) after occupational human immunodeficiency virus (HIV) exposures: findings of the HIV PEP registry [abstract 127-LI-161]. In Program and Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego. September 1998."},{"key":"43_CR33","doi-asserted-by":"crossref","first-page":"913","DOI":"10.7326\/0003-4819-118-12-199306150-00001","volume":"118","author":"JI Tokars","year":"1993","unstructured":"Tokars JI, Marcus R, Culver DH, et al.: Surveillance of HIV infection and zidovudine use among health care workers after occupational exposure to HIV-infected blood. Ann Intern Med 1993, 118:913\u2013919.","journal-title":"Ann Intern Med"},{"key":"43_CR34","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/S0002-9343(97)00064-8","volume":"102","author":"G Ippolito","year":"1997","unstructured":"Ippolito G, Puro V: Zidovudine toxicity in uninfected healthcare workers. Italian Registry of Antiretroviral Prophylaxis. Am J Med 1997, 102:58\u201362.","journal-title":"Am J Med"},{"key":"43_CR35","first-page":"275","volume":"9","author":"J Tannebaum","year":"1997","unstructured":"Tannebaum J, Anastasoff J: The role of psychosocial assessment and support in occupational exposure management. AIDS Educ Prevent 1997, 9:275\u2013284.","journal-title":"AIDS Educ Prevent"},{"key":"43_CR36","unstructured":"Martin JN, Roland ME, Bamberger JD, et al.: Post-exposure prophylaxis (PEP) for sexual exposure to HIV does not lead to increases in high risk behavior: the San Francisco PEP Project. Paper presented at 8th Conference of Retroviruses and Opportunistic Infections. Chicago. February 5, 2001."},{"key":"43_CR37","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/sti.74.2.144","volume":"74","author":"NM Desmond","year":"1998","unstructured":"Desmond NM, Coker RJ: Should preventive antiretroviral treatment be offered following sexual exposure to HIV? The case for. Sex Transm Infect 1998, 74:144\u2013145.","journal-title":"Sex Transm Infect"},{"key":"43_CR38","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1136\/sti.74.2.146","volume":"74","author":"B Evans","year":"1998","unstructured":"Evans B, Darbyshire J, Cartledge J: Should preventive antiretroviral treatment be offered following sexual exposure to HIV? Not yet! Sex Transm Infect 1998, 74:146\u2013148.","journal-title":"Sex Transm Infect"}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-002-0043-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11908-002-0043-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-002-0043-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-002-0043-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T09:57:44Z","timestamp":1659088664000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11908-002-0043-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2002,12]]}},"alternative-id":["43"],"URL":"https:\/\/doi.org\/10.1007\/s11908-002-0043-x","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"value":"1523-3847","type":"print"},{"value":"1534-3146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,12]]},"assertion":[{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}